Delimpasi, Sosana Mateos, Maria Victoria Auner, Holger W. and Gavriatopoulou, Maria Dimopoulos, Meletios A. Quach, Hang and Pylypenko, Halyna Hajek, Roman Leleu, Xavier Dolai, Tuphan Kanti Sinha, Dinesh Kumar Venner, Christopher P. Benjamin, Reuben Garg, Mamta Krishnan Doronin, Vadim Levy, Yair and Moreau, Philippe Chai, Yi Arazy, Melina Shah, Jatin and Shacham, Sharon Kauffman, Michael G. Richardson, Paul G. and Grosicki, Sebastian, Efficacy and tolerability of once-weekly selinexor, bortezomib, and
dexamethasone in comparison with standard twice-weekly bortezomib and
dexamethasone in previously treated multiple myeloma with renal
impairment: Subgroup analysis from the BOSTON study, American Journal of Hematology, (97), E83-E86, 2022, Wiley, 0361-8609, 1096-8652